Effectiveness of the vaccine against COVID-19 in Mexico City
Keywords:
Vaccine, COVID-19 lethality, pandemic.Abstract
Introduction: The COVID-19 pandemic had a significant impact on public health in Mexico, with millions of confirmed cases and hundreds of thousands of deaths. Mass vaccination was implemented as a response, aiming to reduce the mortality rate.
Objective: To evaluate the effectiveness of COVID-19 vaccination in Mexico City by comparing the lethality of the first wave of infections (unvaccinated population) with the third wave (predominantly vaccinated population).
Material and Methods: This is a retrospective observational study that utilized official data from the Mexican Ministry of Health, covering a total of 834,792 confirmed cases in Mexico City. Cases of patients under 18 and over 85 years old were excluded. A logistic regression model was applied, with lethality as the response variable, controlling for age, sex, and comorbidities.
Results: The analysis showed that vaccination significantly reduced the probability of death from COVID-19. However, the protective effect diminished with increasing age. Interactions between age and vaccination were statistically significant, indicating a decrease in efficacy with older age.
Conclusions: COVID-19 vaccination in Mexico City demonstrated a positive effect in reducing lethality. However, its effectiveness decreases with age, highlighting the need for booster strategies and further studies to assess other potential confounding factors, such as virus variants and hospital pressure during different COVID-19 infection waves.Downloads
References
1. CONAHCYT - CentroGeo - GeoInt - DataLab. Covid-19 México [Internet]. México: CONAHCYT - CentroGeo - GeoInt – DataLab; 2022 [Citado 30/01/2022]. Disponible en: https://datos.covid-19.conacyt.mx/#DOView
2. Datosmacro. México - COVID-19 - Vacunas administradas. Our World in Data. [Internet]. México: Datosmacro; 2022 [Citado 30/01/2022]. Disponible en: https://datosmacro.expansion.com/otros/coronavirus-vacuna/mexico
3. Grupo Técnico Asesor de Vacunación Covid-19. Priorización inicial y consecutiva para la vacunación contra SARS-CoV-2 en la población mexicana. Recomendaciones preliminares. Salud Pública de México [Internet]. 2021 [Citado 30/01/2022];63:286-307. Disponible en: https://doi.org/10.21149/12399
4. Hernández-Puente D, Cruz-Martínez D, Luna-Ávila S. COVID-19: Vacunación en México, marzo de 2022. Boletín sobre COVID-19. Universidad Nacional Autónoma de México [Internet]. 2022 [Citado 30/01/2024];3(26). Disponible en: https://dsp.facmed.unam.mx/wp-content/uploads/2022/03/COVID-19-No.26-06-Vacunometro.pdf
5. Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious diseases [Internet]. 2022 [Citado 30/01/2023];22(9):1293–302. https://doi.org/10.1016/S1473-3099(22)00320-6
6. Pérez-Padilla JR, Mora-Pavón A, Hernández-Cárdenas CM, Galindo-Fraga A, Kawa-Karasik S, Espinoza-Bautista KA, et al. Efectividad de las vacunas contra SARS-CoV-2 en hospitalizados con fallas vacunales en 10 hospitales de la CCINSHAE. Salud Publica de México [Internet]. 2022 [Citado 30/01/2022]; 64(2):1316. Disponible en: https://saludpublica.mx/index.php/spm/article/view/13521
7. Parra-Bracamonte GM, López-Villalobos N, Velázquez MA, Parra-Bracamonte FE, Perales-Torres AL, Rendón KJ. Comparative analysis of risk factors for COVID-19 mortality before, during and after the vaccination programme in Mexico. Public Health [Internet]. 2023 [Citado 30/01/2022]; 215:94-99. Disponible en: http://doi.org/10.1016/j.puhe.2022.12.006
8. Lugo-González IV, Pérez-Bautista YY, Fernández-Vega M, Salas-Hernández J, Becerra-Gálvez AL, Reynoso-Erazo L. Psychological factors associated with the intention of getting vaccinated against COVID-19 in Mexico. Neumol Cir Torax [Internet]. 2021[Citado 30/01/2022]; 80(3): 166-72. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0028-37462021000300166&lng=es
9. Gallegos M, Caycho-Rodríguez T. Monitorear el proceso de vacunación COVID-19 en México. Medicina (B. Aires) [Internet]. 2022 [Citado 30/01/2022]; 82(3): 461-2. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802022000500461&lng=es
10. Alcocer-Carranza J, González-Carlo A L, Reyna-Ávila L, Peña-Marcial E, Pérez-Cabañas R. Actitud ante la vacuna contra COVID-19 de los habitantes del Estado de Guerrero, México. Universidad Salud [Internet]. 2022 [Citado 30/01/2022]; 24(2): 108-16. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-71072022000200108&lng=en
11. Secretaría de Salud. Información referente a casos COVID-19 en México [Internet]. México: Datos y Recursos; 2022 [Citado 30/01/2022]. Disponible en: https://datos.gob.mx/busca/dataset/informacion-referente-a-casos-covid-19-en-mexico
12. Hungerford D, Cunliffe NA. Efectividad en el mundo real de las vacunas covid-19. BMJ. 2021; 1(1): 374.
13. López L, Portugal W, Huamán K, Obregón C. Efectividad de vacunas COVID-19 y riesgo de mortalidad en Perú: Un estudio poblacional de cohortes pareadas. Anales de la Facultad de Medicina. 2022; 83(2): 87-94.
14. Scruzzi GF, Aballay LR, Carreño P, Díaz Rousseau GA, Franchini CG, Cecchetto E, et al. Vacunación contra SARS-CoV-2 y su relación con enfermedad y muerte por COVID-19 en Argentina. Revista Panamericana de Salud Pública. 2023; 46: e39.
Download PDF
